Results 21 to 30 of about 609,595 (394)

Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020

MMWR. Morbidity and mortality weekly report, 2021
On March 19, 2020, the governor of California issued a statewide stay-at-home order to contain the spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).* The order reduced accessibility to and patient attendance at outpatient ...
Maureen J Miller, Lanfang Xu, Jin Qin, E. Hahn, Q. Ngo-Metzger, B. Mittman, D. Tewari, M. Hodeib, Patricia Wride, M. Saraiya, C. Chao   +10 more
semanticscholar   +1 more source

Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study

Cancer Cell International, 2021
The incidence rates of cervical cancer in developing countries have been steeply increasing while the medical resources for prevention, detection, and treatment are still quite limited.
Xiangyu Tan, Kexin Li, Jiucheng Zhang, Wenzhe Wang, Bian Wu, Jian Wu, Xiaoping Li, Xiao-yuan Huang   +7 more
semanticscholar   +1 more source

Cervical Cancer Screening [PDF]

JAMA, 2014
of the Clinical Problem Approximately 12 000 new cases of cervical cancer are expected to occur in the United States in 2014, with 4000 deaths from the disease.1 Women younger than 50 years have the highest incidenceofcervicalcancer,andthedisease ismoreprevalent inHispanic andblackwomen.
Anna Volerman, Adam S. Cifu
openaire   +5 more sources

Knowledge on cervical cancer screening and vaccination among females at Oyibi Community

BMC Women's Health, 2021
Background Awareness about cervical cancer screening and vaccination in the developed countries are high as compared to the developing countries. Sixty to eighty percent (60–80%) of the women who develop cervical cancer in sub-Saharan Africa live in the ...
Evans Appiah Osei, Stella Appiah, Judith Elinam Gaogli, Ezekiel Oti-Boadi   +3 more
doaj   +1 more source

Barriers to cervical screening participation in high-risk women [PDF]

, 2015
Aim Women aged 25–35 years, for whom cervical cancer is most problematic, are least likely to participate in the cervical screening programme. Therefore, identifying barriers to screening participation in this high-risk group is essential.
Lovell, Brian, Shepherd, Lee, Wetherell, Mark   +2 more
core   +1 more source

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Journal of Lower Genital Tract Disease, 2020
Rebecca B. Perkins, MD, MSc, Richard S. Guido, MD, Philip E. Castle, PhD, David Chelmow, MD, Mark H. Einstein, MD, MS, Francisco Garcia, MD, MPH, Warner K. Huh, MD, Jane J.
R. Perkins, R. Guido, P. Castle, D. Chelmow, M. Einstein, Francisco A. R. Garcia, W. Huh, Jane J. Kim, A. Moscicki, R. Nayar, M. Saraiya, G. Sawaya, N. Wentzensen, M. Schiffman   +13 more
semanticscholar   +1 more source

Human papillomavirus infection in women undergoing in-vitro fertilization: effects on embryo development kinetics and live birth rate

Reproductive Biology and Endocrinology, 2023
Backgroud Several studies showed that human papillomavirus (HPV) affects male fertility, but its impact on female fertility and in vitro fertilization (IVF) outcome is not yet clear.
Federica Zullo, Valentina Fiano, Anna Gillio-Tos, Sara Leoncini, Ginevra Nesi, Luigia Macrì, Mario Preti, Alessandro Rolfo, Chiara Benedetto, Alberto Revelli, Laura De Marco   +10 more
doaj   +1 more source

PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening. [PDF]

, 2020
BackgroundWomen aged 50-70 should receive breast, cervical (until age 65), and colorectal cancer (CRC) screening; men aged 50-70 should receive CRC screening and should discuss prostate cancer screening (PSA).
Dass, Natasha, Gildengorin, Ginny, Green, Lawrence, Ozer, Elizabeth, Potter, Michael, Salazar, Rene, Walsh, Judith   +6 more
core   +1 more source

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears

Diagnostic Pathology, 2019
Background p16/Ki-67 dual immunocytochemical staining (DS) has been proven as a sensitive and specific test for triage of HPV positive women with good reproducibility and accuracy.
Veronika Kloboves Prevodnik, Tine Jerman, Nataša Nolde, Alenka Repše Fokter, Sandra Jezeršek, Živa Pohar Marinšek, Ulrika Klopčič, Simona Hutter Čelik, Kristina Gornik Kramberger, Maja Primic Žakelj, Urška Ivanuš   +10 more
doaj   +1 more source

Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study

BMC Women's Health, 2022
Background Women living with Human Immunodeficiency Virus (HIV) are at a high risk for early development of cervical cancer. Adherence to cervical cancer prevention strategies in this population is vital for the early detection and treatment of cervical ...
Najjuka Sarah Maria, Connie Olwit, Mark Mohan Kaggwa, Rose Chalo Nabirye, Tom Denis Ngabirano   +4 more
doaj   +1 more source